New shingles vaccine Z-1018 takes on shingrix in Head-to-Head trial
⭐️ VACCINE ⭐️
Recruiting now
This study tests a new shingles vaccine called Z-1018 in about 764 healthy adults aged 50 and older. Researchers want to see if it is safe and triggers a strong immune response compared to the current vaccine, Shingrix. The trial involves two doses and will monitor side effects a…
Phase: PHASE1, PHASE2 • Sponsor: Dynavax Technologies Corporation • Aim: ⭐️ VACCINE ⭐️
Last updated May 06, 2026 16:14 UTC